sitaxsentan sodium

DRUG2 trials

Sponsors

ICOS-Texas Biotechnology, Encysive Pharmaceuticals

Conditions

Pulmonary Hypertension

Phase 2

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

ICOS-Texas BiotechnologyPulmonary Hypertension

Target: 180Updated: 2005-06-24

Phase 3

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

CompletedNCT00080457

Encysive PharmaceuticalsPulmonary Hypertension

Start: 2003-05-31End: 2005-01-31Target: 240Updated: 2007-11-09